82565

Creatinine; blood

Creatinine is a waste product produced from the normal breakdown of creatine phosphate in skeletal muscle. It is freely filtered by the glomeruli in the kidneys and minimally reabsorbed or secreted by the renal tubules. Because of its relatively constant production rate and efficient renal excretion, serum (blood) creatinine concentration serves as one of the most widely used and cost-effective biomarkers for assessing renal function, particularly the glomerular filtration rate (GFR). CPT code 82565 specifically covers the quantitative measurement of creatinine in a blood sample (serum or plasma). Elevated serum creatinine levels typically indicate a decrease in GFR, suggesting impaired kidney function. This can occur in various conditions, including acute kidney injury (AKI), chronic kidney disease (CKD), dehydration, congestive heart failure, and urinary tract obstruction. The magnitude of creatinine elevation often correlates with the severity of renal impairment, though factors like muscle mass, age, sex, diet, and certain medications can influence baseline levels. For instance, individuals with greater muscle mass or those consuming a high-meat diet may have slightly higher normal creatinine levels, while the elderly or those with significant muscle wasting may have lower levels despite impaired kidney function. Serum creatinine is routinely measured as part of comprehensive metabolic panels, basic metabolic panels, and for monitoring patients with known kidney disease or those at risk. It is a critical component in estimating GFR using formulas like the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) equation or the MDRD (Modification of Diet in Renal Disease) equation, which provide a more accurate assessment of kidney function than creatinine alone. This measurement is vital for diagnosing kidney disease, staging its progression, adjusting dosages of renally excreted medications, and assessing overall patient health before surgery or other medical interventions. The analytical methods commonly employed include the Jaffe reaction (colorimetric) and enzymatic assays, performed on automated chemistry analyzers. Accurate and timely measurement of blood creatinine is indispensable for managing kidney health and preventing complications associated with renal dysfunction.

Clinical Indications

  • Screening for kidney disease as part of routine health check-ups.
  • Diagnosis and monitoring of acute kidney injury (AKI).
  • Diagnosis, staging, and monitoring of chronic kidney disease (CKD).
  • Assessment of kidney function prior to administering nephrotoxic drugs or drugs with renal elimination (e.g., certain antibiotics, chemotherapy agents).
  • Pre-surgical evaluation to assess renal reserve and identify potential risks.
  • Monitoring patients with conditions that can affect kidney function, such as diabetes, hypertension, heart failure, and autoimmune diseases.
  • Evaluation of patients presenting with symptoms suggestive of renal dysfunction (e.g., edema, fatigue, changes in urination).
  • Assessment of hydration status.
  • Monitoring after kidney transplantation.

Procedure Steps

  1. Patient Preparation: Typically, no special patient preparation (e.g., fasting) is required for a routine creatinine test, though some laboratories or clinicians may request it if other tests are ordered concurrently.
  2. Sample Collection (Venipuncture): A trained phlebotomist or healthcare professional performs venipuncture, usually from a superficial vein in the antecubital fossa. Blood is drawn into a Vacutainer tube, commonly a serum separator tube (SST) with a clot activator and gel separator (red or gold top) or a lithium heparin tube (green top) for plasma.
  3. Sample Processing: For serum: The blood sample is allowed to clot (typically 15-30 minutes at room temperature), then centrifuged to separate serum from blood cells. For plasma: The heparinized blood sample is immediately centrifuged to separate plasma from blood cells. The separated serum or plasma is then aliquoted into a secondary tube for analysis.
  4. Analytical Method: Jaffe Reaction (Colorimetric): The most common method. Creatinine reacts with picric acid in an alkaline solution to form a red-orange chromogen (Janovski complex), which is measured spectrophotometrically at 500-520 nm. This method is inexpensive but can be prone to interference from non-creatinine chromogens (e.g., glucose, ascorbic acid, proteins, acetoacetate, bilirubin) leading to overestimation. Enzymatic Methods: These methods utilize enzymes (e.g., creatininase, creatinase, sarcosine oxidase, peroxidase) to convert creatinine into products that can be quantified spectrophotometrically. Enzymatic assays are generally more specific, less prone to interference, and often preferred for improved accuracy, especially at lower creatinine concentrations.
  5. Measurement and Calibration: The sample is loaded onto an automated chemistry analyzer. The analyzer performs the reaction, measures the absorbance, and calculates the creatinine concentration by comparing it to a calibration curve established with known standards.
  6. Quality Control: Internal and external quality control materials are run regularly to ensure the accuracy, precision, and reliability of the test results.
  7. Reporting: The creatinine concentration is reported in milligrams per deciliter (mg/dL) or micromoles per liter (µmol/L), along with the laboratory's reference range.

Coding Guidelines

  • CPT code 82565 specifically describes "Creatinine; blood." This code should be used for the quantitative measurement of creatinine in a serum or plasma sample.
  • This code is typically reported once per encounter, even if multiple measurements are performed during the same encounter for immediate clinical decision-making, unless distinct clinical reasons for separate tests are documented and justified.
  • Creatinine is often included in various laboratory panels (e.g., CPT 80047 Basic Metabolic Panel, 80048 Basic Metabolic Panel (hospital), 80053 Comprehensive Metabolic Panel, 80069 Renal Function Panel). When billed as part of a panel, it is not separately billable. If performed individually, 82565 is appropriate.
  • Medicare Part B covers medically necessary laboratory tests. Clinical documentation must support the necessity of the creatinine test (e.g., signs/symptoms of kidney disease, monitoring known kidney disease, medication management).
  • The use of modifier -59 (Distinct Procedural Service) or -91 (Repeat Clinical Diagnostic Laboratory Test) is generally not applicable for repeat creatinine measurements on the same date by the same lab, unless there is a clear, distinct clinical indication and new specimen for the repeat test. For instance, if a creatinine is done pre-procedure and then again post-procedure on the same day due to an acute change in patient status, documentation would be key.
  • Be mindful of local coverage determinations (LCDs) or national coverage determinations (NCDs) that may specify frequency limits or diagnostic requirements for creatinine testing.

Associated ICD-10 Codes